Predicting death or major neurodevelopmental disability in extremely preterm infants born in Australia.

RA Boland; PG Davis; JA Dawson; LW Doyle; Victorian Infant Collaborative Study Group

Journal article

Predicting death or major neurodevelopmental disability in extremely preterm infants born in Australia.

RA Boland, PG Davis, JA Dawson, LW Doyle, undefined Victorian Infant Collaborative Study Group

Archives of Disease in Childhood Fetal and Neonatal Edition | BMJ PUBLISHING GROUP | Published : 2013

DOI: 10.1136/archdischild-2012-301628

Abstract

The aim of this study was to determine if the National Institute of Child Health and Human Development (NICHD) calculator, designed to predict mortality or neurosensory disability in infants 22-25 weeks' gestation, was valid for contemporary Australian infants. Outcome data at 2 years of age for 114 infants who were liveborn in Victoria, Australia, in 2005, between 22 and 25 completed weeks' gestation, weighing 401-1000 g at birth, and free of lethal anomalies, were entered into the NICHD online calculator. Predicted outcomes were then compared with the actual outcomes. Of the 114 infants, 99 (87%) were inborn and 15 (13%) were outborn. The overall prediction of death for inborn infants was ..

View full abstract

University of Melbourne Researchers

Peter Davis Author

Lex Doyle Author

Rosemarie Boland Author

Related Projects (2)

Evaluating Intensive Care for Tiny Babies

Most extremely tiny babies, those of birthweight less than 1000 g, need intensive care to survive. However some survivors have substantial p..

IMPROVED RESPIRATORY SUPPORT AND OUTCOMES FOR VERY PRETERM BABIES

Premature babies are born with lungs that are not developed enough to sustain their breathing needs after birth. As a result, they need inte..

Grants

Awarded by Clinical Centre for Research Excellence in Newborn Medicine (National Health and Medical Research Council (NHMRC))

Awarded by Australian NHMRC Programme

Awarded by NHMRC

Funding Acknowledgements

RAB is the recipient of the Felix Meyer Faculty Research Scholarship from The University of Melbourne, and receives funding from the Clinical Centre for Research Excellence in Newborn Medicine (National Health and Medical Research Council (NHMRC) Grant No. 546519). JAD is the recipient of a National Health and Medical Research Council (NHMRC) postdoctoral fellowship. PGD and LWD hold an Australian NHMRC Programme Grant No. 606789. Also funded in part by NHMRC Project Grant No. 454413, and the Department of Innovation, Industry and Regional Development (Victorian Government).